Reset filter
Palabras clave
Augenheilkunde ×
Mostrar más Palabras clave
Tabla de contenido
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

595 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

INTRAOCULAR PRESSURE (DAY 0) CRFs Roche FVF4170G Macular Edema NCT00473382

- 9/6/17 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Patient administration, INTRAOCULAR PRESSURE (DAY 0)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

PATIENT REPORTED OUTCOME AND QUESTIONNAIRES RetDQoL (DAY 0) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 2 itemgroups, 4 items, 1 idioma
Itemgroups: Patient administration, PATIENT REPORTED OUTCOME AND QUESTIONNAIRES (DAY 0)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

PATIENT REPORTED OUTCOME AND QUESTIONNAIRES (DAY 0) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 2 itemgroups, 4 items, 1 idioma
Itemgroups: Patient administration, PATIENT REPORTED OUTCOME AND QUESTIONNAIRES (DAY 0)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

4 METER VISUAL ACUITY / LEFT EYE CHART 2 (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 6 itemgroups, 39 items, 1 idioma
Itemgroups: Patient administration, 4 METER VISUAL ACUITY / LEFT EYE CHART 2 (SCREENING) CONTINUED, SECTION I = 4 Meter Test, SECTION II = 1 Meter Test, SECTION III = Computing VA Score & Snellen Equivalent, SECTION IV = Low Vision Testing
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

4 METER VISUAL ACUITY / RIGHT EYE CHART 1 (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 6 itemgroups, 39 items, 1 idioma
Itemgroups: Patient administration, 4 METER VISUAL ACUITY / RIGHT EYE CHART 1 (SCREENING), SECTION I = 4 Meter Test, SECTION II = 1 Meter Test, SECTION III = Computing VA Score & Snellen Equivalent, SECTION IV = Low Vision Testing
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

INTRAOCULAR PRESSURE (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 2 itemgroups, 9 items, 1 idioma
Itemgroups: Patient administration, INTRAOCULAR PRESSURE (SCREENING)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

SLITLAMP EXAMINATION (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 3 itemgroups, 49 items, 1 idioma
Itemgroups: Patient administration, SLITLAMP EXAMINATION (SCREENING), SLITLAMP EXAMINATION (SCREENING)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

INDIRECT OPHTHALMOSCOPY (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 3 itemgroups, 45 items, 1 idioma
Itemgroups: Patient administration, INDIRECT OPHTHALMOSCOPY (SCREENING), INDIRECT OPHTHALMOSCOPY (SCREENING)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

ALCOHOL / TOBACCO USE HISTORY (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Patient administration, ALCOHOL / TOBACCO USE HISTORY (SCREENING)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

PHYSICAL EXAM (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 2 itemgroups, 5 items, 1 idioma
Itemgroups: Patient administration, PHYSICAL EXAM (SCREENING)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

GENERAL MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 3 itemgroups, 8 items, 1 idioma
Itemgroups: Patient administration, GENERAL MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING), Other Medical History
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

TARGETED MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 8/6/17 - 1 formulario, 2 itemgroups, 118 items, 1 idioma
Itemgroups: Patient administration, TARGETED MEDICAL HISTORY AND BASELINE CONDITIONS (SCREENING)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial